Methotrexate maintenance following Ingram therapy in 'difficult' psoriasis.
A retrospective analysis is presented summarizing 9 years' experience using a combined regime of Ingram therapy followed by methotrexate maintenance in the management of especially difficult psoriatic patients. The lesion-free period was extended from about 1 month (controls) to 1 year, and the period before re-admission was extended from 5 months to more than 3 years.
D000875:Anthralin / Q000627:therapeutic use; D003033:Coal Tar / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy* / Q000628:therapy; D012189:Retrospective Studies; D014467:Ultraviolet Therapy
D003033:Coal Tar; D000875:Anthralin; D008727:Methotrexate